Ocugen to Present at Retinal Vascular Disease Drug Development Summit

Go back to Ocugen to Present at Retinal Vascular Disease Drug Development Summit
(NASDAQ: OCGN) Delayed: 1.40 +0.03 (2.19%)
Previous Close $1.37    52 Week High
Open $1.37    52 Week Low
Day High $1.42    P/E N/A 
Day Low $1.37    EPS
Volume 3,175,958